A highly anticipated drug trial is in its final stages as its 350 participants receive their single dose to treat chronic low back pain. If successful, the experimental medication could be a breakthrough therapeutic for people with the common but debilitating condition. Continue Reading Category: Chronic Pain , Illnesses and conditions , Body and Mind , Refractor: Science & Health Tags: Cells , Back Pain , Low back pain , clinical trials , Regenerative Medicine , Chronic pain , Age-Related